NEW YORK – Bioinformatic analysis startup Constantiam Biosciences said on Monday that it has been awarded a $2.05 million Phase II Small Business Innovation Research (SBIR) grant from the US…
LEADERSHIP MESSAGE
Check out the OHSU’s newsletter highlighting Constantiam’s agreement with OHSU to license data from the lab of Dr. Brian O’Roak. Learn More.
Read More
Multiplexed Assays of Variant Effect (or MAVEs) are a type of functional evidence that can be applied within the ACMG/AMP framework for classifying genetic variants. In this post, we cover…
MAVEs for clinical variant interpretation – opportunities and challenges
In our last blog post, we introduced Multiplexed Assays of Variant Effect (MAVEs) and gave an overview of how they can be…
Chris Evert, a name synonymous with tennis excellence, has navigated many challenges both on and off the court. Her life, marked by incredible achievements in tennis, took a profound turn…
What are MAVEs and how can they be used in clinical variant classification?
Multiplexed Assays of Variant Effect (or MAVEs) are a type of functional evidence that can be applied…
In honor of breast cancer awareness month, we’d like to dedicate this post to exploring how MAVEs can ensure that breast cancer is detected as early as possible. A study…
